Aspirin may slow recurrence in breast cancer patients
- Details
- Category: Research
New findings published in the journal Cancer Research reveal that some postmenopausal overweight breast cancer patients who use common anti-inflammatory drugs like aspirin or ibuprofen have significantly lower breast cancer recurrence rates. Researchers from the Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio and the University of Texas at Austin began by examining blood serum from CTRC breast cancer patients, said CTRC oncologist Andrew Brenner, M.D., Ph.D.
Cell discovery brings blood disorder cure closer
- Details
- Category: Research
A cure for a range of blood disorders and immune diseases is in sight, according to scientists who have unravelled the mystery of stem cell generation. The Australian study, led by researchers at the Australian Regenerative Medicine Institute (ARMI) at Monash University and the Garvan Institute of Medical Research, is published in Nature. It identifies for the first time mechanisms in the body that trigger hematopoietic stem cell (HSC) production.
Bone drugs may not protect osteoporotic women from breast cancer
- Details
- Category: Research
Osteoporosis drugs known as bisphosphonates may not protect women from breast cancer as had been thought, according to a new study led by researchers at UC San Francisco (UCSF). The drugs' protective effect was widely assumed after several observational studies showed that women who took them were less likely to get breast cancer.
Newly discovered heart molecule could lead to effective treatment for heart failure
- Details
- Category: Research
Researchers have discovered a previously unknown cardiac molecule that could provide a key to treating, and preventing, heart failure. The newly discovered molecule provides the heart with a tool to block a protein that orchestrates genetic disruptions when the heart is subjected to stress, such as high blood pressure.
Study shows type 2 diabetics can live longer than people without the disease
- Details
- Category: Research
Patients treated with a drug widely prescribed for type 2 diabetes can live longer than people without the condition, a large-scale study involving over 180,000 people has shown. The findings indicate that a drug known as metformin, used to control glucose levels in the body and already known to exhibit anticancer properties, could offer prognostic and prophylactic benefits to people without diabetes.
In search for Alzheimer's drug
- Details
- Category: Research
Researchers at Yale School of Medicine have discovered a new drug compound that reverses the brain deficits of Alzheimer's disease in an animal model. Their findings are published in the Aug. 5 issue of the journal PLoS Biology. The compound, TC-2153, inhibits the negative effects of a protein called STtriatal-Enriched tyrosine Phosphatase (STEP), which is key to regulating learning and memory.
Aspirin: Scientists believe cancer prevention benefits outweigh harms
- Details
- Category: Research
New research from Queen Mary University of London (QMUL) reveals taking aspirin can significantly reduce the risk of developing - and dying from - the major cancers of the digestive tract, i.e. bowel, stomach and oesophageal cancer. For the first time, scientists have reviewed all the available evidence from many studies and clinical trials assessing both the benefits and harms of preventive use of aspirin.
More Pharma News ...
- Safety concerns about new drugs revealed
- Pepper and halt: Spicy chemical may inhibit gut tumors
- Recent use of some birth control pills may increase breast cancer risk
- Five daily portions of fruit and vegetables may be enough to lower risk of death
- Scientists discover new, noncommittal mechanism of drug resistance
- Drugs used to treat lung disease work with the body clock
- Paracetamol no better than placebo for lower back pain